Company news

Evolus, Inc. Common Stock news in 2026

Evolus, Inc. Common Stock's news releases, calls and decks from 2026, newest first.

View company

Evolus to Participate in Upcoming Investor Conferences in New York and London

October 28, 2026

Evolus to Report Third Quarter Financial Results on November 4, 2026

October 21, 2026

Evolus Expands Innovation Pipeline with Novel Injectable Hair Restoration Program

October 14, 2026

Evolus Launches Wings by Evolus, a New Charitable Platform to Mobilize Its Community in Support of Important Causes

October 1, 2026

Evolus Reports Strong Second Quarter 2026 Financial Results; Delivers Third Consecutive Quarter of Positive Adjusted EBITDA and Raises Full-Year 2026 Financial Outlook

August 5, 2026

Evolus Expands Strategic Partnership with Symatese to Commercialize Estyme® in Canada, Australia, and New Zealand

August 4, 2026

Evolus to Report Second Quarter Financial Results on August 5, 2026

July 22, 2026

Evolus Announces Partnership with IBSA to Develop and Commercialize Market-Leading Profhilo® in the United States, Expanding Its Injectable Portfolio into Skin Quality

July 7, 2026

Evolus to Participate in The Jefferies Global Healthcare Conference

May 18, 2026

Evolus Announces Commercial Launch of Estyme® Injectable Hyaluronic Acid Gels in Europe

May 11, 2026

Evolus Reports First Quarter 2026 Financial Results; Company Delivers Second Consecutive Quarter of Positive Adjusted EBITDA and Reaffirms Full-Year Outlook

May 4, 2026

Evolus to Report First Quarter Financial Results on May 4, 2026

April 14, 2026

Evolus to Participate in the Needham 25th Annual Virtual Healthcare Conference

March 31, 2026

Evolus Reports Fourth Quarter and Full-Year 2025 Financial Results; Delivers Sixth Consecutive Year of Double-Digit Growth and Expects Sustainable Profitability1 Beginning in 2026

March 3, 2026

Evolus Reports Fourth Quarter and Full-Year 2025 Financial Results; Delivers Sixth Consecutive Year of Double-Digit Growth and Expects Sustainable Profitability¹ Beginning in 2026

March 2, 2026

Evolus to Participate in The Leerink Partners Global Healthcare Conference

February 25, 2026

Evolus to Report Fourth Quarter and Full-Year 2025 Financial Results on March 3, 2026

February 17, 2026

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 13, 2026

Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2025 Net Revenue

January 9, 2026

Calls in 2026

Decks in 2026